1. Drug repurposing analysis with co-expressed genes identifies novel drugs and small molecules for bladder cancer
   Esra Göv et al, 2024, Journal of Scientific Reports-A CrossRef
2. LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer
   Jingqi Shi et al, 2020, Frontiers in Oncology CrossRef
3. Identification of Co-Deregulated Genes in Urinary Bladder Cancer Using High-Throughput Methodologies
   George I. Lambrou et al, 2021, Applied Sciences CrossRef
4. Exploiting protein family and protein network data to identify novel drug targets for bladder cancer
   Tolulope Tosin Adeyelu et al, 2022, Oncotarget CrossRef
5. A two-way rectification method for identifying differentially expressed genes by maximizing the co-function relationship
   Bolin Chen et al, 2021, BMC Genomics CrossRef
6. FGFR3, TERT, ТР53 mutations and the FGFR3 gene expression in bladder cancer as prognostic markers
   D. S. Mikhaylenko et al, 2021, Cancer Urology CrossRef